SHARECARE INC (SHCR) Fundamental Analysis & Valuation
NASDAQ:SHCR • US81948W1045
Current stock price
1.43 USD
-0.01 (-0.35%)
At close:
1.43 USD
0 (0%)
After Hours:
This SHCR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SHCR Profitability Analysis
1.1 Basic Checks
- In the past year SHCR has reported negative net income.
- In the past year SHCR has reported a negative cash flow from operations.
- SHCR had negative earnings in each of the past 5 years.
- In multiple years SHCR reported negative operating cash flow during the last 5 years.
1.2 Ratios
- SHCR has a Return On Assets of -24.25%. This is comparable to the rest of the industry: SHCR outperforms 54.05% of its industry peers.
- The Return On Equity of SHCR (-31.01%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.25% | ||
| ROE | -31.01% | ||
| ROIC | N/A |
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SHCR has a Gross Margin of 44.04%. This is in the lower half of the industry: SHCR underperforms 67.57% of its industry peers.
- SHCR's Gross Margin has declined in the last couple of years.
- SHCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
2. SHCR Health Analysis
2.1 Basic Checks
- SHCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, SHCR has less shares outstanding
- The debt/assets ratio for SHCR is higher compared to a year ago.
2.2 Solvency
- SHCR has an Altman-Z score of 0.73. This is a bad value and indicates that SHCR is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of 0.73, SHCR perfoms like the industry average, outperforming 48.65% of the companies in the same industry.
- SHCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.73 |
ROIC/WACCN/A
WACC9.12%
2.3 Liquidity
- SHCR has a Current Ratio of 2.02. This indicates that SHCR is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of SHCR (2.02) is comparable to the rest of the industry.
- A Quick Ratio of 2.02 indicates that SHCR has no problem at all paying its short term obligations.
- SHCR has a Quick ratio of 2.02. This is comparable to the rest of the industry: SHCR outperforms 59.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 2.02 |
3. SHCR Growth Analysis
3.1 Past
- The earnings per share for SHCR have decreased strongly by -11.43% in the last year.
- SHCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.11%.
- SHCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.63% yearly.
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%
3.2 Future
- SHCR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.33% yearly.
- SHCR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.95% yearly.
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. SHCR Valuation Analysis
4.1 Price/Earnings Ratio
- SHCR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SHCR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.49%
EPS Next 3Y11.33%
5. SHCR Dividend Analysis
5.1 Amount
- No dividends for SHCR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SHCR Fundamentals: All Metrics, Ratios and Statistics
1.43
-0.01 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-09 2024-08-09/bmo
Earnings (Next)11-07 2024-11-07/bmo
Inst Owners38.79%
Inst Owner Change0%
Ins Owners0.1%
Ins Owner Change0%
Market Cap531.79M
Revenue(TTM)403.70M
Net Income(TTM)-135.87M
Analysts48.89
Price Target1.46 (2.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.56%
Min EPS beat(2)-68.07%
Max EPS beat(2)-47.05%
EPS beat(4)1
Avg EPS beat(4)-39.36%
Min EPS beat(4)-68.07%
Max EPS beat(4)8.5%
EPS beat(8)1
Avg EPS beat(8)-38.89%
EPS beat(12)2
Avg EPS beat(12)-55.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.26%
Min Revenue beat(2)-12.09%
Max Revenue beat(2)-2.43%
Revenue beat(4)0
Avg Revenue beat(4)-6.75%
Min Revenue beat(4)-12.09%
Max Revenue beat(4)-2.22%
Revenue beat(8)3
Avg Revenue beat(8)-2.77%
Revenue beat(12)5
Avg Revenue beat(12)-2.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.32 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.21 | ||
| P/tB | 4.32 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS1.09
BVpS1.18
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.25% | ||
| ROE | -31.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.04% | ||
| FCFM | N/A |
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.08% | ||
| Cap/Sales | 0.17% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | 0.73 |
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)6.08%
Cap/Depr(5y)6.54%
Cap/Sales(3y)0.6%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A
EBIT growth 1Y-15.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.69%
EBIT Next 3Y30.06%
EBIT Next 5YN/A
FCF growth 1Y82.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.64%
OCF growth 3YN/A
OCF growth 5YN/A
SHARECARE INC / SHCR Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for SHARECARE INC?
ChartMill assigns a fundamental rating of 3 / 10 to SHCR.
What is the valuation status for SHCR stock?
ChartMill assigns a valuation rating of 0 / 10 to SHARECARE INC (SHCR). This can be considered as Overvalued.
How profitable is SHARECARE INC (SHCR) stock?
SHARECARE INC (SHCR) has a profitability rating of 1 / 10.
What is the earnings growth outlook for SHARECARE INC?
The Earnings per Share (EPS) of SHARECARE INC (SHCR) is expected to grow by 4.89% in the next year.